Small human trials show NMN reliably lifts blood NAD+, with mixed results on everything else. We cover the doses tested, the safety gaps and what to realistically expect.
In part. Across small, short human trials using 250 to 1,250 mg a day, NMN consistently raised blood NAD+. A handful reported modest shifts in muscle insulin sensitivity, walking distance or grip strength. Still, findings are mixed, NMN makers paid for several of the trials, and no human study has shown that NMN slows aging.
NMN (nicotinamide mononucleotide) is a form of vitamin B3. The body turns it into NAD+, a molecule involved in energy metabolism and cell repair. NAD+ is thought to decline with age, and that's the reasoning behind NMN supplements. So far the human trials have been small, with about 10 to 110 people, and short, lasting 2 to 12 weeks.
A well-known example is the 2021 Washington University trial (Yoshino et al.). It gave 250 mg a day for 10 weeks to 25 postmenopausal women with prediabetes and reported better muscle insulin sensitivity. Trials in healthy middle-aged and older adults saw higher blood NAD+ and, sometimes, small changes in walking speed or grip strength. Other outcomes didn't move.
In trials of up to about three months, NMN was well tolerated at 250 to 2,000 mg a day, and side effects were no more common than with placebo. No one has published results for people who take it for a year or longer. Talk to your doctor first if you're pregnant, breastfeeding or under 18, if you're being treated for cancer or have had it, or if you take diabetes or blood pressure medicines.
Our top pick among NMN supplements is GenuinePurity NMN. Each 2-capsule serving gives 500 mg of NMN, within the range used in trials, and a 97-day guarantee with conditions applies. The product itself hasn't been tested, and its "liposomal" absorption claim is unproven. Also note that the $19 trial offer auto-renews at $49 a month.